Skip to content

FutureCrest Acquisition FCRS Deferred Offering Costs Noncurrent

Deferred Offering Costs Noncurrent at other companies

KRAKacquisition
 logo
KRAKacquisition KRAQ
$436.02K
Enliven Therapeutics logo
Enliven TherapeuticsELVN
$217K
Annexon logo
AnnexonANNX
$445K+449%
Oaktree Specialty Lending logo
Oaktree Specialty LendingOCSL
$43K-73.3%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$200K-33.3%
Sonida Senior Living logo
Sonida Senior LivingSNDA
$0

Other financials

Income statement

See full
Operating income-$869.4K
Net income$1.7M
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$719.8K
Total equity-$12.1M
Total assets$293.9M

Cash flow

See full
Operating cash flow-$149.8K

Valuation

See full
Market cap$366.56M+0.2%
P/E91.4×

Returns & leverage

See full
Return on equity-34.4%
Current ratio

Where this comes from

Reported directly by FutureCrest Acquisition in its filing.

Tagged under the XBRL concept fcrs:DeferredOfferingCostsNoncurrent.

The official record: FutureCrest Acquisition ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about FutureCrest Acquisition 's deferred offering costs noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is FutureCrest Acquisition 's deferred offering costs noncurrent?
FutureCrest Acquisition (FCRS) reported deferred offering costs noncurrent of $12.25M in Q1 2026.
What does deferred offering costs noncurrent mean?
Deferred offering costs represent expenses incurred in connection with a capital raise or public offering that are capitalized and amortized over the life of the related equity or debt instrument. These costs are classified as noncurrent when they are expected to be recognized beyond the next fiscal year. Monitoring these costs is important for understanding the total capital expenditure associated with financing activities.